170 related articles for article (PubMed ID: 35064580)
1. Immunomodulator FTY720 improves glucose homeostasis and diabetic complications by rejuvenation of β-cell function in nonhuman primate model of diabetes.
Wang YJ; Wang X; An A; Zang M; Xu L; Gong K; Song W; Li Q; Lu X; Xiao YF; Yu G; Ma ZA
Fundam Clin Pharmacol; 2022 Aug; 36(4):699-711. PubMed ID: 35064580
[TBL] [Abstract][Full Text] [Related]
2. The sphingosine-1-phosphate receptor modulator, FTY720, prevents the incidence of diabetes in Spontaneously Diabetic Torii rats.
Kobayashi K; Sasase T; Ishii Y; Katsuda Y; Miyajima K; Yamada T; Ohta T
Clin Exp Pharmacol Physiol; 2021 Jun; 48(6):869-876. PubMed ID: 32920892
[TBL] [Abstract][Full Text] [Related]
3. FTY720 preserved islet β-cell mass by inhibiting apoptosis and increasing survival of β-cells in db/db mice.
Moon H; Chon J; Joo J; Kim D; In J; Lee H; Park J; Choi J
Diabetes Metab Res Rev; 2013 Jan; 29(1):19-24. PubMed ID: 22936676
[TBL] [Abstract][Full Text] [Related]
4. FTY720 normalizes hyperglycemia by stimulating β-cell in vivo regeneration in db/db mice through regulation of cyclin D3 and p57(KIP2).
Zhao Z; Choi J; Zhao C; Ma ZA
J Biol Chem; 2012 Feb; 287(8):5562-73. PubMed ID: 22194608
[TBL] [Abstract][Full Text] [Related]
5. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
Weng J
J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic approach for type 1 diabetes mellitus using the novel immunomodulator FTY720 (fingolimod) in combination with once-daily injection of insulin glargine in non-obese diabetic mice.
Tsuji T; Inoue M; Yoshida Y; Fujita T; Kaino Y; Kohno T
J Diabetes Investig; 2012 Mar; 3(2):132-7. PubMed ID: 24843556
[TBL] [Abstract][Full Text] [Related]
7. Depletion of T lymphocytes ameliorates cardiac fibrosis in streptozotocin-induced diabetic cardiomyopathy.
Abdullah CS; Li Z; Wang X; Jin ZQ
Int Immunopharmacol; 2016 Oct; 39():251-264. PubMed ID: 27494688
[TBL] [Abstract][Full Text] [Related]
8. Prevention, but not cure, of autoimmune diabetes in a NOD.scid transfer model by FTY720 despite effective modulation of blood T cells.
Morris MA; McDuffie M; Nadler JL; Ley K
Autoimmunity; 2011 Mar; 44(2):115-28. PubMed ID: 20695767
[TBL] [Abstract][Full Text] [Related]
9. Metformin plus low-dose glimeperide significantly improves Homeostasis Model Assessment for insulin resistance (HOMA(IR)) and beta-cell function (HOMA(beta-cell)) without hyperinsulinemia in patients with type 2 diabetes mellitus.
Bermúdez-Pirela VJ; Cano C; Medina MT; Souki A; Lemus MA; Leal EM; Seyfi HA; Cano R; Ciscek A; Bermúdez-Arias F; Contreras F; Israili ZH; Hernández-Hernández R; Valasco M
Am J Ther; 2007; 14(2):194-202. PubMed ID: 17414590
[TBL] [Abstract][Full Text] [Related]
10. Oral therapy for type 1 diabetes mellitus using a novel immunomodulator, FTY720 (fingolimod), in combination with sitagliptin, a dipeptidyl peptidase-4 inhibitor, examined in non-obese diabetic mice.
Tsuji T; Yoshida Y; Fujita T; Kohno T
J Diabetes Investig; 2012 Oct; 3(5):441-8. PubMed ID: 24843604
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin type-1 receptor blockade with losartan increases insulin sensitivity and improves glucose homeostasis in subjects with type 2 diabetes and nephropathy.
Jin HM; Pan Y
Nephrol Dial Transplant; 2007 Jul; 22(7):1943-9. PubMed ID: 17308317
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine-1-phosphate receptor agonist, FTY720, restores coronary flow reserve in diabetic rats.
Xu H; Jin Y; Ni H; Hu S; Zhang Q
Circ J; 2014; 78(12):2979-86. PubMed ID: 25319164
[TBL] [Abstract][Full Text] [Related]
13. Natural product vindoline stimulates insulin secretion and efficiently ameliorates glucose homeostasis in diabetic murine models.
Yao XG; Chen F; Li P; Quan L; Chen J; Yu L; Ding H; Li C; Chen L; Gao Z; Wan P; Hu L; Jiang H; Shen X
J Ethnopharmacol; 2013 Oct; 150(1):285-97. PubMed ID: 24012527
[TBL] [Abstract][Full Text] [Related]
14. Effects of a fermented buckwheat flower and leaf extract on the blood glucose and lipid profile of type 2 diabetic db/db mice.
Wang J; Yu X; Jiang Y; Wang Y; Li Y; Han S
J Tradit Chin Med; 2020 Apr; 40(2):197-203. PubMed ID: 32242385
[TBL] [Abstract][Full Text] [Related]
15. Effect of sphingosine 1-phosphate (S1P) receptor agonists FTY720 and CYM5442 on atherosclerosis development in LDL receptor deficient (LDL-R⁻/⁻) mice.
Poti F; Costa S; Bergonzini V; Galletti M; Pignatti E; Weber C; Simoni M; Nofer JR
Vascul Pharmacol; 2012 Aug; 57(1):56-64. PubMed ID: 22459073
[TBL] [Abstract][Full Text] [Related]
16. Long-term islet graft survival in streptozotocin- and autoimmune-induced diabetes models by immunosuppressive and potential insulinotropic agent FTY720.
Fu F; Hu S; Deleo J; Li S; Hopf C; Hoover J; Wang S; Brinkmann V; Lake P; Shi VC
Transplantation; 2002 May; 73(9):1425-30. PubMed ID: 12023620
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine-1-Phosphate Receptor Modulator, FTY720, Improves Diastolic Dysfunction and Partially Reverses Atrial Remodeling in a Tm-E180G Mouse Model Linked to Hypertrophic Cardiomyopathy.
Ryba DM; Warren CM; Karam CN; Davis RT; Chowdhury SAK; Alvarez MG; McCann M; Liew CW; Wieczorek DF; Varga P; Solaro RJ; Wolska BM
Circ Heart Fail; 2019 Nov; 12(11):e005835. PubMed ID: 31684756
[TBL] [Abstract][Full Text] [Related]
18. FTY720 impairs CD8 T-cell function independently of the sphingosine-1-phosphate pathway.
Ntranos A; Hall O; Robinson DP; Grishkan IV; Schott JT; Tosi DM; Klein SL; Calabresi PA; Gocke AR
J Neuroimmunol; 2014 May; 270(1-2):13-21. PubMed ID: 24680062
[TBL] [Abstract][Full Text] [Related]
19. [A new therapeutic approach for autoimmune diseases by the sphingosine 1-phosphate receptor modulator, fingolimod (FTY720)].
Chiba K
Nihon Rinsho Meneki Gakkai Kaishi; 2009 Apr; 32(2):92-101. PubMed ID: 19404007
[TBL] [Abstract][Full Text] [Related]
20. Xenograft of microencapsulated Sertoli cells for the cell therapy of type 2 diabetes mellitus in spontaneously diabetic nonhuman primates: preliminary data.
Luca G; Cameron DF; Arato I; Mancuso F; Linden EH; Calvitti M; Falabella G; Szekeres K; Bodo M; Ricci G; Hansen BC; Calafiore R
Transplant Proc; 2014; 46(6):1999-2001. PubMed ID: 25131093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
